Citi, Hims
Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...
Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...
Teladoc's growth and profitability challenges continue amid rising competition. Learn why TDOC stock remains under pressure ...
OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...
What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...
The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.
Ratings for Hims & Hers Health HIMS were provided by 12 analysts in the past three months, showcasing a mix of bullish and ...
Hims & Hers Health (NYSE:HIMS – Free Report) had its target price lifted by Piper Sandler from $21.00 to $24.00 in a report ...
Bearish flow noted in Hims and Hers Health with 25,948 puts trading, or 1.4x expected. Most active are Mar-25 27 puts and Jan-25 26 puts, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback